Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Tasso Gets CE Mark for At-Home Blood Collection Device
The Tasso-M20 device was designed for the collection, storage, and transport of blood samples for analyzing drug levels or monitoring biomarkers.
Burning Rock Biotech, Abbisko Therapeutics Ink CDx Partnership for ABSK091
Burning Rock will use its sequencing platform to identify urothelial carcinoma patients with FGFR alterations, supporting development of Abbisko's drug.
Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B
Thermo Fisher will acquire PPD for $47.50 per share for a total price of $17.4 billion, plus the assumption of approximately $3.5 billion in debt.
BTIG Initiates Coverage of NeoGenomics With Buy Rating
BTIG highlighted the firm's cancer test portfolio, as well as its growing position in the liquid biopsy and minimal residual disease testing space.
PMC Report Outlines Strong Growth, Future Challenges for Personalized Medicine Industry
As adoption of personalized medicines has accelerated over the last four years, so has the number of marketed genetic and exome tests.